Tekcis

Tekcis (Pertechnetate Tc 99m Sodium) is a radiopharmaceutical used in nuclear medicine for diagnostic imaging. This sterile, non-pyrogenic solution helps visualize organs and tissues during scans. Commonly used for thyroid, salivary gland, and brain imaging. Short half-life ensures minimal radiation exposure.

Pertechnetate Tc 99m Sodium is primarily used in diagnostic imaging procedures to evaluate organ function and detect abnormalities. It is commonly employed for thyroid imaging, salivary gland scans, and brain perfusion studies. The radiopharmaceutical helps identify issues such as tumors, cysts, or blockages in these areas. It may also assist in detecting gastrointestinal bleeding or Meckel’s diverticulum.

After administration, the radiopharmaceutical distributes in the body and emits gamma rays detectable by imaging equipment. Patients may experience mild discomfort at the injection site. Some individuals report a metallic taste or flushing shortly after injection. These effects are typically transient and resolve without intervention.

Tekcis should only be handled by qualified healthcare professionals trained in radiopharmaceutical use. Proper shielding and protective measures are required to minimize radiation exposure. Pregnant or breastfeeding individuals should avoid use unless medically necessary. Patients should inform their provider of any allergies or prior reactions to radiopharmaceuticals.

No known drug interactions have been established for Pertechnetate Tc 99m Sodium. However, certain medications or recent imaging studies using contrast agents may affect scan results. Patients should disclose all current medications, including supplements, to their healthcare provider. Alcohol consumption is not known to interact but may be restricted based on individual health conditions.